Search by Medical Condition

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Clinical Trials for Spondylitis

• Efficacy and Safety of SCT650C in Participants With Axial Spondyloarthritis
• Baricitinib in the Treatment of Refractory Axial Spondyloarthritis Patients: A Comparison With Tofacitinib
• ToFAcitinib in Early Active Axial SpondyloarThritis:
• A Study of LNK01001 Capsule in Patients With Ankylosing Spondylitis
• Extension Study to Evaluate Safety and Efficacy of Jaktinib in Patients With Active Ankylosing Spondylitis(AS)
• Efficacy and Safety Study of Jaktinib in Subjects With Active Ankylosing Spondylitis(AS)
• Efficacy and Safety Clinical Study of VC005 Tablets in Subjects With Active Ankylosing Spondylitis.
• Optimizing Anti-IL17 Antibody Therapy by Associating Fiber Supplementation to Correct Treatment-aggravated Gut Dysbiosis in Axial Spondyloarthritis - RESPOND-IL17
• A Phase 3 Program Evaluating the Effect of Filgotinib in Participants With Active Axial Spondyloarthritis
• The Efficacy of Fecal Microbiota Transplatation on Axial Spondyloarthritis Patients Resistant to Conventional Treatment
• A Study of Secukinumab to Evaluate Maintenance of Response in Participants With Non-radiographic Axial Spondyloarthritis Who Achieved Remission
• The Clinical Efficacy and the Changes of Immune Cells Subsets With Bioagents in Ankylosing Spondylitis Patients
• Phase II Study of Hemay005 in Patients With Active Ankylosing Spondylitis
• Oral Vitamin D and Toll Like Receptor in Spondylitis Tuberculosis
• A Study Evaluating the Efficacy of Secukinumab 300mg in Chinese Adults With Active Ankylosing Spondylitis
• Terbinafine Treatment of Axial Spondyloarthropathy
• A Study of CC-99677 in Participants With Active Ankylosing Spondylitis
• Efficacy and Safety of Yuxuebi Tablet in Treating Night Pain of Ankylosing Spondylitis (AS).
• Compare the Effect of Eupatilin and Rebamipide on the Prevention of Gastroenteropathy
• Evaluation of the Optimal Concentration Range of Adalimumab for Ankylosing Spondylitis in a Prospective Observational Cohort Study
• Efficacy and Safety of SHR-1314 in Patients With Active Ankylosing Spondylitis
• ABY-035 in the Treatment of Subjects With Ankylosing Spondylitis
• A Study of Ixekizumab (LY2439821) in Children With Juvenile Idiopathic Arthritis Categories of Enthesitis-related Arthritis (Including Juvenile Onset Ankylosing Spondylitis) and Juvenile Psoriatic Arthritis
• Jaktinib Hydrochloride Tablets In The Treatment of Active Ankylosing Spondylitis
• Study to Evaluate the Efficacy and Safety of Filgotinib in Participants With Active Ankylosing Spondylitis Who Are Naive to Biologic Disease-Modifying Antirheumatic Drug Therapy
• Study to Evaluate the Efficacy and Safety of Filgotinib in Participants With Active Ankylosing Spondylitis Who Have an Inadequate Response to Biologic Disease-Modifying Antirheumatic Drug Therapy
• A Study to Evaluate the Efficacy and Safety of SHR0302 in Patients With Ankylosing Spondylitis
• Bawei Shenqi Pill in the Treatment of Ankylosing Spondylitis
• A Study to Evaluate the Long-term Safety, Tolerability and Efficacy of Bimekizumab in Subjects With Active Axial Spondyloarthritis Including Ankylosing Spondylitis and Nonradiographic Axial Spondyloarthritis
• Safety and Efficacy Study of Prefilled Liquid Etanercept(Yisaipu) for Active Ankylosing Spondylitis
• Phase 1 Study With KIN-1901 in Healthy Subjects and Subjects With Ankylosing Spondylitis
• Study to Demonstrate the Efficacy, Safety and Tolerability of an Intravenous Regimen of Secukinumab Compared to Placebo in Subjects With Active axSpA
• A Phase III Study Evaluate the Efficacy and Safety of BAT1406 and Humira
• Treat-to-target Strategy in Ankylosing Spondylitis Using Etanercept and Conventional Synthetic DMARDs
• Tofacitinib for Reduction of Spinal Inflammation in Patients With Psoriatic ArthritiS PresenTing With Axial InvOlvement
• Comparison of PK and Tolerability of MSB11022 Administered by AI or PFS
• A Multicenter，Double-Blind and Randomized Controlled Trial of Fengshigutong Capsule in the Treatment of Ankylosing Spondylitis
• A Study to Evaluate the Efficacy and Safety of Bimekizumab in Subjects With Active Ankylosing Spondylitis
• Study to Evaluate the Effect of Filgotinib on Semen Parameters in Adult Males With Active Rheumatoid Arthritis, Psoriatic Arthritis, Ankylosing Spondylitis, or Non-radiographic Axial Spondyloarthritis
• Treat-to-Target Strategy With Etanercept for Ankylosing Spondylitis
• Efficacy and Safety of Loxoprofen Hydrogel Patch in Patients With Ankylosing Spondylitis
• A Study of Golimumab in the Treatment of Indian Participants With Active Spondyloarthropathy of Ankylosing Spondylitis or Psoriatic Arthritis
• Treat-to-target With Secukinumab in Axial Spondyloarthritis
• Prediction of Treatment Response at 6 Months by Combinatorial Analysis of Serum Biomarkers in Biotherapy Naive SpA
• Long-Term Extension Trial of Tildrakizumab to Prove Its Safety in Subjects With Psoriatic Arthritis Who Have Previously Completed Study With Tildrakizumab.
• Efficacy and Safety of Tofacitinib in Subjects With Active Ankylosing Spondylitis (AS)
• Non-Steroidal Anti-inflammatory Drugs in Axial Spondyloarthritis
• International Multicenter Comparative Randomized Placebo-controlled Clinical Study of Efficacy and Safety of BCD-085 in Patients With Ankylosing Spondylitis
• Sequential Application of Yisaipu® and DMARDs in Treating Mild-to-Moderate AS
• Study to Test the Safe and Effective Use of an e-Device for the Self-injection of Certolizumab Pegol Solution by Subjects With Moderate to Severe Active Rheumatoid Arthritis, Active Ankylosing Spondylitis, Active Psoriatic Arthritis, or Moderately t
• A Study to Evaluate the Long Term Safety and Efficacy of Bimekizumab in Subjects With Ankylosing Spondylitis
• Study Estimating the Clinical Difference Between 300 mg and 150 mg of Secukinumab Following Dose Escalation to 300 mg in Patients With Ankylosing Spondylitis
• A Study of Experimental Medication BMS-986251, Taken by Mouth, in Healthy Participants and Patients With Average to Very Serious Psoriasis
• A Study to Test the Efficacy and Safety of Bimekizumab and Certolizumab Pegol in Patients With Active Ankylosing Spondylitis
• A Study Evaluating the Safety and Efficacy of Upadacitinib in Adults With Active Ankylosing Spondylitis
• The Effects of Nanocurcumin on Treg Cells and Th17 Cells Responses in Ankylosing Spondylitis Patients
• A Study to Assess Efficacy and Safety of Filgotinib in Ankylosing Spondylitis
• Prediction of the Answer to the Treatment by Biotherapies for Naive Spondyloarthritis by Combinatorial Analysis of Serum Biomarkers
• Efficacy and Safety Study of SUNPG1622
• A Study to Evaluate the Efficacy and Safety of Different Doses of Bimekizumab in Subjects With Active Ankylosing Spondylitis
• Incidence of Hospitalizations for Serious Infections in Patients Receiving Biologic Anti-Inflammatories for Rheumatologic, Psoriatic, and Gastrointestinal Conditions: A Descriptive Analysis
• Relapse of Ankylosing Spondylitis Patients Withdrawal Etanercept After Clinical Remission: a Following-up Study
• Study of Efficacy and Safety of Secukinumab in Patients With Ankylosing Spondylitis
• Efficacy and Safety of IBI303 in Adult Patients With Active Ankylosing Spondylitis
• C.O.R.P.U.S.: Observational Cohort of Adult and Child Inflammatory Arthritis in France
• Effect of Biological Disease Modifying Anti Rheumatic Drug (bDMARD) Treatment on Spinal Fracture Incidence in Patients With Ankylosing Spondylitis (AS)
• A Pilot Study of MSCs Iufusion and Etanercept to Treat Ankylosing Spondylitis
• Clinical Trial to Evaluate Efficacy and Safety of Multiple Subcutaneous Injections of Various Doses of BCD-085 in Patients With Active Ankylosing Spondylitis
• Study to Examine the Clinical Efficacy and the Nonsteroidal Anti-inflammatory Drug (NSAID)-Sparing Effect of Secukinumab Over 16 Weeks in Patients With Ankylosing Spondylitis
• NSAIDs Added to Anti-TNF Therapy Versus Anti-TNF Therapy Alone on Progression of Structural Damage in Ankylosing Spondylitis
• Study of Efficacy and Safety of Secukinumab in Japanese Patients With Active Ankylosing Spondylitis
• Dose Reduction of Etanercept in Patients With Ankylosing Spondylitis
• Post-Marketing Use Of CT-P13 (Infliximab) For Standard Of Care Treatment Of Rheumatoid Diseases Who Are Naïve To Biologics Or Switched From Remicade
• Safety and Effectiveness of Live Zoster Vaccine in Anti-Tumor Necrosis Factor (TNF) Users (VERVE Trial)
• Safety and Effectiveness of Live Zoster Vaccine in Anti-Tumor Necrosis Factor (TNF) Users (VERVE Trial)
• A Study Of Celecoxib Versus Diclofenac In Patients With Ankylosing Spondylitis
• Biomarkers Identification of Anti-tumor Necrosis Factor (TNF) α Agent's Efficacy in Ankylosing Spondylitis Patients
• Interest of Continuous Non-Steroidal Anti-Inflammatory Drug Treatment in Ankylosing Spondylitis Patients Treated by Anti-TNF Therapy in the Prevention of Radiographic Outcomes
• Anti-Tumor Necrosis Factor Therapy In Patients With Ankylosing Spondylitis
• An Efficacy and Safety Study of Ustekinumab in Participants With Active Nonradiographic Axial Spondyloarthritis
• Comparative Evaluation of Pharmacokinetics and Safety of BCD-055 and Remicade in Patients With Ankylosing Spondylitis
• 99mTc-rhAnnexin V-128 a Phase I/IIa Study in Patients With Rheumatoid Arthritis (RA) or Ankylosing Spondylitis (AS)
• Combined Treatment With TNF Inhibitor and Pamidronate in AS Patients: Effect on the Radiographic Progression
• An Observational Study of Infliximab in Participants Suffering From Ankylosing Spondylitis With Hip Involvement
• Defining Remission With Etanercept in AS in Real Life Clinical Practice
• Phase II Clinical Study of Thalidomide in the Treatment of Ankylosing Spondylitis
• A Study of Golimumab in Participants With Active Ankylosing Spondylitis
• Evaluation of Efficacy and Safety of Meloxicam Suppository (15mg Daily) and Tablet (15 mg Daily) Compared to Indomethacin Suppository (50 mg Daily) in Patients With Ankylosing Spondylitis
• Effects of Biological Treatment on Blood Pressure and Endothelial Function in Patients With Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis
• BI 655066 (Risankizumab) Proof of Concept Dose Finding Study in Ankylosing Spondylitis (AS)
• 16-week Efficacy and 3-year Safety, Tolerability and Efficacy of Secukinumab in Active Ankylosing Spondylitis Patients
• Induction of Regulatory t Cells by Low Dose il2 in Autoimmune and Inflammatory Diseases
• Etanercept and Celecoxib Alone/Combined Treatment in Effectiveness and Safety of Active Ankylosing Spondylitis
• Effect of the Combination of Methotrexate and Adalimumab on Reduction of Immunization in Ankylosing Spondylitis (COMARIS)
• Study of Ixekizumab in Participants With Active Ankylosing Spondylitis (AS)
• Remicade in the Treatment of Patients With Active Ankylosing Spondylitis
• An Observational, Retrospective, Multicenter, National Study for the Monitoring of Subjects Who Participated in the LoadET Clinical Trial
• Efficacy and Safety of MEthylprednisolone Administered Intravenously for the Treatment of Patients With Active AnkyLosing spondyLitis (METALL)
• Dose-Ranging Study Of Tofacitinib In Adults With Active Ankylosing Spondylitis
• A Molecule Basic Study of Early Warning for New Pathogenic Risk of Ankylosing Spondylitis
• Study of Anti-Viral Prophylaxis for HBsAg(+) or HBcAb(+)/HBsAb(-) Patients Starting Anti-TNFα
• A Study to Assess the Safety and Effectiveness of Golimumab in Filipino Patients With Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis
• Etoricoxib Prescribing Patterns and Adverse Events of Interest in Primary Care in the United Kingdom (MK-0663-162 AM1)
• 16 Week Efficacy and 5 Year Long Term Efficacy, Safety and Tolerability of Secukinumab in Patients With Active Ankylosing Spondylitis
• Effect of Spacing of Anti-TNF Drugs in Ankylosing Spondylitis With Low Disease Activity
• Study of Apremilast to Treat Subjects With Active Ankylosing Spondylitis
• Total Glucosides Paeony Capsules in Maintaining Clinical Remission in Patients With Ankylosing Spondylitis Which Achieve Clinical Remission After Anti-TNF Therapy
• Work Productivity in Active Ankylosing Spondylitis (AS) Patients Treated With Enbrel.
• A Study of Rheumatoid Arthritis Treatment With Enbrel in Adult Patient in Outpatient Department
• Effects of Rosuvastatin on Carotid Artery Plaques in Patients With Inflammatory Joint Disease
• Effect Of Anti TNF Alpha Therapy And Their Adverse Effects In Ankylosing Spondylitis In A North Indian Population
• 16 Week Efficacy and 2 Year Long Term Safety and Efficacy of Secukinumab in Patients With Active Ankylosing Spondylitis
• Ustekinumab for the Treatment of Patients With Active Ankylosing Spondylitis
• Safety of Etoricoxib (MK-0663) in Patients With Spondyloarthropathy (SpA)/Ankylosing Spondylitis (AS) in Sweden (EP07013.013.11.082)
• A Study to Investigate the Use of Golimumab (Simponi®) in Participants With Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis (P06554)
• Etanercept (Enbrel) in Ankylosing Spondylitis
• Study Comparing Etanercept (ETN) Against a Placebo for Etanercept on a Background Nonsteroidal Anti Inflammatory Drug (NSAIDs) in the Treatment of Early Spondyloarthritis (SpA) Patients Who do Not Have X-ray Structural Changes
• Study of the Safety and Efficacy of Golimumab in Chinese Patients With Ankylosing Spondylitis
• Program evaLuating the Autoimmune Disease iNvEstigational Drug cT-p13 in AS Patients(PLANETAS)
• Effect of Anti-TNF (Alpha) Treatment on Vascular Stiffness in Ankylosing Spondylitis (AS)
• A Study of RoActemra/Actemra (Tocilizumab) in Patients With Ankylosing Spondylitis Who Have Failed Treatment With NSAIDs
• A Study of Tocilizumab (RoActemra/Actemra) in Patients With Ankylosing Spondylitis Who Have Had an Inadequate Response to Previous Tumor Necrosis Factor (TNF) Antagonist Therapy
• A Two-Part 26-Week Study of Etoricoxib as Treatment for Ankylosing Spondylitis (AS) (MK-0663-108)
• Observational Non-Interventional Study With Enbrel (Etanercept) in Patients With Ankylosing Spondylitis
• Intestinal Inflammation in Ankylosing Spondylitis and the Effects of Adalimumab on Mucosal Healing
• Effectiveness and Safety of Early Treatment With Infliximab for Hip Arthritis Associated With Ankylosing Spondylitis (AS) (P06451)
• Extension Study for Long Term Evaluation of SAR153191 (REGN88) in Patients With Ankylosing Spondylitis
• Treatment With Alendronate in Patients With Ankylosing Spondylitis (AS)
• Assessment of the Response to Etoricoxib in Patients With Ankylosing Spondylitis and Inadequate Response to ≥2 NSAIDs
• Golimumab Safety and Surveillance Program Using the Ingenix NHI Database
• Heart Function in Rheumatoid Arthritis and Ankylosing Spondylitis Pre and Post-TNF Blocker
• Dose Ranging Study to Evaluate the Efficacy and Safety of SAR153191 (REGN88) in Patients With Ankylosing Spondylitis
• T Cells and TNF (Tumor Necrosis Factor): The Impact of TNF Blockade
• Efficacy and Safety of Risedronate (Actonel), a Third Generation Bisphosphonate in Patients With Ankylosing Spondylitis: a Phase 2 Pilot Study
• Efficacy and Safety of Kunxian Capsule in Treatment Patients With Early Ankylosing Spondylitis
• Spondylitis Trial of Apremilast for Better Rheumatic Therapy
• Efficacy and Safety Study of Infliximab (Remicade) to Treat Early Ankylosing Spondylitis
• Effects of Etanercept on the Heart, Veins and Thickness of Certain Major Arteries In Ankylosing Spondylitis Patients
• Clinical Study of Tripterygium Capsule to Treat Early Ankylosing Spondylitis
• Study Evaluating Etanercept in Subjects With Ankylosing Spondylitis in Spain
• Infliximab for Treatment of Axial Spondyloarthritis (P05336 AM1)
• A Study of ARRY-371797 in Patients With Active Ankylosing Spondylitis
• Double Blind, Placebo Controlled Study to Assess Efficacy of AIN457 in Moderate to Severe Ankylosing Spondylitis
• An Efficacy and Safety Study of Tramadol/Acetaminophen Versus Diclofenac in the Treatment of Pain in Participants With Ankylosing Spondylitis Receiving Stable Treatment of Disease Modifying Anti-rheumatic Drugs (DMARDs)
• Study Of Celecoxib Or Diclofenac For Efficacy and Safety In Chinese Patients With Ankylosing Spondylitis
• An Observational Study of Infliximab Injection in Ankylosing Spondylitis, Rheumatoid Arthritis, Psoriatic Arthritis and Psoriasis Participants
• Effects of Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) on RAdiographic Damage in Ankylosing Spondylitis
• Enthesitis With Ultra Sonography Doppler in Spondyloarthropathies Treated With Infliximab (Study P04440)
• Safety and Efficacy of Celecoxib Versus Diclofenac in the Treatment of Ankylosing Spondylitis
• Tramadol/Acetaminophen(Ultracet) AS add-on Therapy in the Treatment of Patients With Ankylosing Spondylitis
• PReventive Efficacy and Safety of rEbamipide on Nsaid Induced Mucosal Toxicity
• Pilot Open Label Clinical Trial With Abatacept in Ankylosing Spondylitis
• Study Evaluating The Use Of Etanercept In Patients With Ankylosing Spondylitis
• Infliximab and Methotrexate in Ankylosing Spondylitis
• An Open-Label Study to Evaluate the Response to Adalimumab in Patients With Active Ankylosing Spondylitis Who Have Failed Standard Therapy or TNF-Alpha Inhibitors (RHAPSODY)
• Study Evaluating Etanercept in Patients With Ankylosing Spondylitis
• An Open-Label Multicentre Long-Term Extension Study of Etanercept for Ankylosing Spondylitis
• Study of Two Schedules of Infliximab Maintenance Therapy in Ankylosing Spondylitis
• Study Evaluating Etanercept in the Treatment of Subjects With Ankylosing Spondylitis
• Open Label Clinical Trial With Rituximab (MabThera ®) in Ankylosing Spondylitis
• Combination Methotrexate and Infliximab
• An Open-Label, Multicentre, Long-Term Extension Study of Etanercept in Ankylosing Spondylitis
• Study Evaluating Etanercept Treatment of Patients With Ankylosing Spondylitis
• Study Evaluating Etanercept for the Treatment of Active, Severe, and Advanced Axial Ankylosing Spondylitis
• Study Comparing Etanercept 50 mg Once Weekly to 25 mg Twice Weekly in Patients With Ankylosing Spondylitis
• Extension Study Evaluating Etanercept in Ankylosing Spondylitis
• Study to Evaluate the Incidence of Gastric Ulcers Following Administration of Either PN 200 or Naproxen in Subjects Who Are at Risk for Developing NSAID-Associated Ulcers.
• 16.0040 Ankylosing Spondylitis Study
• Epsilon-Aminocaproaic Acid to Reduce the Need for Blood Transfusions During and Following Spine Surgery
• Methotrexate in the Treatment of Axial Spondyloarthritis
• Study Evaluating Etanercept and Sulphasalazine in Ankylosing Spondylitis
• Prednisolone in Active Ankylosing Spondylitis (AS)
• Methotrexate in Ankylosing Spondylitis (MTX in AS)
• Examination of Radiographic Progression, Efficacy and Safety of Long-Term Treatment With Infliximab in Patients With Ankylosing Spondylitis
• D2E7-Early AS
• The RATIO: Registry of Infections and Lymphoma in Patients Treated With TNF-a Antagonists
• A Study of Infliximab (Remicade) in Patients With Ankylosing Spondylitis.
• Study Investigating Enbrel Treatment for Ankylosing Spondylitis
• TNFalfa Blocking Treatment of Spondylarthropathies
• Phase II Pilot Study of Olsalazine for Ankylosing Spondylitis
• Blocking Tumor Necrosis Factor in Ankylosing Spondylitis